Ładuje się......
Topical rapamycin (sirolimus) for facial angiofibromas
Rapamycin (sirolimus) is a fungal fermentation product that inhibits the proper functioning of a serine/threonine protein kinase in mammalian cells eponymously named mammalian target of rapamycin, or mTOR. Rapamycin is a novel class of anticancer and immunosuppressant drugs targeting the proteins at...
Zapisane w:
| 1. autor: | |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Medknow Publications & Media Pvt Ltd
2013
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573457/ https://ncbi.nlm.nih.gov/pubmed/23439391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-5178.105488 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|